n(g),n(g')-dimethyl-l-arginine has been researched along with Branch Vein Occlusion in 2 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA) is considered an independent cardiovascular risk factor (cvRF) and thus represents a potential new biomarker for retinal vein occlusion (RVO)." | 8.02 | [Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study]. ( Binder, H; Closs, EI; Gericke, A; Habermeier, A; Pfeiffer, N; Ponto, KA; Rosner, AK; Scharrer, I, 2021) |
| "Asymmetric dimethylarginine (ADMA) is considered an independent cardiovascular risk factor (cvRF) and thus represents a potential new biomarker for retinal vein occlusion (RVO)." | 4.02 | [Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study]. ( Binder, H; Closs, EI; Gericke, A; Habermeier, A; Pfeiffer, N; Ponto, KA; Rosner, AK; Scharrer, I, 2021) |
| "We investigated the levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), as well as homocysteine and cysteine thiols, in a cohort of subjects affected by retinal vein occlusion (RVO) disease." | 3.74 | Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease. ( Carru, C; Carta, F; Deiana, L; Gaspa, L; Pinna, A; Sotgia, S; Usai, MF; Zinellu, A; Zinellu, E, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosner, AK | 1 |
| Closs, EI | 1 |
| Habermeier, A | 1 |
| Gericke, A | 1 |
| Binder, H | 1 |
| Scharrer, I | 1 |
| Pfeiffer, N | 1 |
| Ponto, KA | 1 |
| Zinellu, A | 1 |
| Pinna, A | 1 |
| Sotgia, S | 1 |
| Zinellu, E | 1 |
| Usai, MF | 1 |
| Carta, F | 1 |
| Gaspa, L | 1 |
| Deiana, L | 1 |
| Carru, C | 1 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Branch Vein Occlusion
| Article | Year |
|---|---|
[Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].
Topics: Aged; Arginine; Humans; Hypertension; Retinal Vein Occlusion; Risk Factors | 2021 |
Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease.
Topics: Aged; Arginine; Case-Control Studies; Cohort Studies; Cysteine; Female; Humans; Male; Middle Aged; R | 2008 |